{"id":"W2022970282","doi":"10.1371/journal.pone.0108694","title":"A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Teva Pharmaceutical Industries; Leukemia and Lymphoma Society","keywords":"Medicine; Adverse effect; Toxicity; Phases of clinical research; Myeloid leukemia; Somnolence; Gastroenterology; Internal medicine; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001518387,0.001309392,0.001580254,0.0003248048,0.0004523743,0.0005356029,0.0006785308,0.0006587069,0.00200711],"category_scores_gemma":[0.0007059224,0.0004981207,0.0007231392,0.0003580942,0.0009034085,0.0006568707,0.0002739569,0.002105013,0.0005372152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005422824,"about_ca_system_score_gemma":0.00154323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007580674,"about_ca_topic_score_gemma":0.001796111,"domain_scores_codex":[0.9996291,0.0001902967,0.00002485825,0.00007059839,0.00002897783,0.00005612985],"domain_scores_gemma":[0.9990956,0.0001118001,0.0002167685,0.0000725338,0.00005651973,0.0004467355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6532312,0.09536235,0.01907181,0.0006069064,0.0008549521,0.0003232564,0.000393724,0.002656141,0.1311225,0.0001914743,0.00217024,0.09401537],"study_design_scores_gemma":[0.3906833,0.5779974,0.02231999,0.00002617605,0.0003127092,0.0002841995,0.0000681489,0.001023561,0.005318412,0.0000913587,0.001848833,0.00002592202],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971541,0.0007046219,0.0003786347,0.0001194056,0.00004405357,0.0009879161,0.0002286164,0.00003211749,0.0003504078],"genre_scores_gemma":[0.9934241,0.0009580187,0.001902139,0.0004717422,0.000130293,0.001451016,0.0008833795,0.00002127413,0.0007581974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00200711,"threshold_uncertainty_score":0.008030057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03177334780687289,"score_gpt":0.297787225955216,"score_spread":0.266013878148343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}